glp-1 and serotonin The Multifaceted Nature of GLP-1: Molecular Mechanisms Signaling Pathways in Metabolic and Neurodegenerative Diseases New research shows GLP-1 medications

Schedule a consultation to find out which option fits your goals

Gut microbiome and depression: what we know and what we need to know

Injecting cold medication can increase injection site discomfort, while poor site rotation may lead to lipohypertrophy or lipoatrophy

Coverage rules and dollar amounts reflect 2026 CMS guidelines and are subject to change

These include: Nausea and vomiting typically most pronounced during dose escalation and often improving with continued use Diarrhoea or constipation affecting bowel habit regularity Abdominal pain and discomfort ranging from mild cramping to more significant discomfort Dyspepsia and gastro-oesophageal reflux related to delayed gastric emptying Injection site reactions are classified as 'common' (affecting up to 1 in 10 people) and may include redness, itching, bruising, or localised swelling at the subcutaneous injection site